Mapp Biopharmaceutical has contracted Avid Bioservices, a biologics contract development and manufacturing organization (CDMO), to provide process transfer, scale-up and clinical manufacturing services to support one of its development programs for a novel antiviral drug candidate. Avid and Mapp will immediately commence the initial phase of the project.   “We are extremely delighted and honored that Mapp Biopharmaceutical contracted Avid Bioservices as their CDMO to support the company’s antivi...